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ABSTRACT. The practice of medicine by future physicians is going to be greatly influenced by knowledge
obtained from biotechnology. For instance, the development of DNA-based, prenatal diagnoses for inherited
genetic disease or the availability of cloned protein hormones or vaccines will require that physicians have a
different basic science background than their predecessors. This will necessitate changes in how the basic
sciences are taught in medical schools. Suggestions are offered regarding the teaching of biotechnology to
medical students.
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INTRODUCTION
Over the last few years it has become very clear to those
who read the scientific literature that there has been an
almost exponential growth in the number of articles that
involve genetic engineering, recombinant DNA, or some
other aspect of biotechnology (Schmidtke et al. 1986).
Indeed, Schmidtke et al. (1986) speculated that if the
present growth in the number of reports of cloned genes
was maintained, their number would be greater than all
other scientific publications by 1994. Many of these ar-
ticles relate to questions that affect directly or indirectly
the lives of many people. Examples include the genetics
of color vision (Nathans et al. 1986), the understanding
of the LDL receptor system (Sudhof et al. 1985), the
analysis of genetic diseases (Williamson 1985, Wion et al.
1986), development of sensitive assays for malaria (Guntaka
et al. 1986), and the development of new strains of agri-
cultural products (Marx 1985). In a recent meeting at
Cold Spring Harbor on the "Molecular Biology of Homo
sapiens" (Lewin 1986a), McKusick (1986a) noted that the
number of isolated human genes had doubled in the last
four years, and that the number of autosomal assignments
increased five-fold in the last 10 years (McKusick
1986b). At the same meeting, Gilbert (Lewin 1986b)
speculated on the feasibility of sequencing the whole
human genome, which has some 3 X 109 nucleotides.
To some, these articles and statements are indicative of
the exciting and novel time that we live in, but to the
majority, these events either may not be understood or
misunderstood. Clearly, an effort has to be made to edu-
cate and/or inform people about the benefits of bio-
technology, while at the same time pointing out any
potential problems that may arise from its widespread
applications. The question then becomes how, when, and
where does this education start?
Many aspects of biotechnology must be taught to med-
ical students. However, the basics of biotechnology
should also be explained to college undergraduates, and
even high school seniors, with the proviso that the basics
are explained in a way that is interesting and easy to
understand. One of the quickest ways to lose a student
audience is to give boring lectures. For example, there is
nothing to be gained from showing students one DNA
sequence after another, since most of the information
contained in these sequences is of interest to only a few
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scientists. Somehow the key point of the DNA sequence,
say, of an insect globin gene, has to be simply sum-
marized and clearly stated. For example, there are no
introns in insect globin genes (Antoine and Niessing
1984); this makes the system different from that of hu-
mans and other eucaryotes. Once this point has been
mentioned, the actual sequence of nucleotides, and so on,
becomes irrelevant. A wide variety of globin gene fami-
lies can easily be compared with each other or to plant
leghemoglobins (which have three introns), without
ever having to show a single DNA sequence. Naturally,
there has to be a reason for the comparison; otherwise the
students first get confused, then stop paying attention to
the lectures. It is obvious that an explanation of why the
globin gene families are being compared has to be first
given to the students.
The following discussion will focus on the teaching of
biotechnology to medical students. Suggestions will also
be offered on teaching undergraduates and high school
seniors.
BIOTECHNOLOGY AND THE MEDICAL
STUDENT
At Northeastern Ohio Universities College of Medi-
cine (NEOUCOM), there is no formal course in molecu-
lar biology, but the last half of the fall semester of
biochemistry (which is taught all three semesters) covers
topics such as nucleotide biosynthesis, DNA and RNA
structure, gene organization, and prenatal diagnosis. The
students are told very early in the course that, when they
graduate, patients may ask them about DNA-based, pre-
natal diagnoses, or they may be prescribing insulin and
growth hormone to patients, both of which can be ob-
tained from genetically engineered bacteria. This is one
of the background "reasons" for the students having to
learn this material. The value of the recombinant DNA
products is also explained briefly in terms of supply, cost,
and purity. The latter is of particular importance because
of the recent deaths of several patients who had received
cadaveric human growth hormone (Koch et al. 1985).
The lectures in the fall semester focus on the red cell;
the last seven weeks use replication, transcription, and
translation as a means of explaining globin synthesis. The
series gets tied together by a detailed analysis of the
molecular basis of the thalassemias. This detailed analysis
enables examples of gene mutations, population genetics,
and pre-natal diagnosis to be brought to the attention of
the students. A textbook is not used for this section of the
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semester, primarily because the information on thal-
assemias, prenatal diagnosis, cloning, and the like, is
changing so rapidly. The students are given basic older
information plus selected examples from the recent liter-
ature. This requires the lecturers to spend an enormous
amount of time reading the literature and culling and
processing suitable material. However, a benefit re-
sulting from this effort is that the medical students find
this "new" information quite interesting and begin to
appreciate how rapidly knowledge is accumulating. An
excellent example of this is the knowledge regarding the
thalassemias. For a long time, most of the available in-
formation was about (3 thalassemia; however, over the
last one to two years, an enormous amount of data has be-
come available regarding the a thalassemias. In fact, a
thalassemia is now regarded as the most common single
gene disease in the world (Flint et al. 1986). A con-
stant searching of the literature for teaching material
really pays off. For example, the inheritance of homo-
zygous a°thalassemia is lethal, and is referred to as kydrops
fetalis (Kan 1986). There is one example (published in
an abstract form), however, of a Chinese infant who
was born prematurely and transfused before the diagnosis
was established. The infant has reached the age of one
year with monthly transfusions; his future physical and
mental development might indicate whether heroic
treatment for o;°thalassemia is warranted (Yanofsky et al.
1984). This exception raises many economic, social,
and ethical issues, which will be addressed for the first
time by NEOUCOM medical students during the fall,
1986, lectures.
Occasionally, ethical issues are mentioned in the class-
room, but in a careful, neutral manner. Material is used
from such diverse sources as the Medical Journal of Austra-
lia (Bell and Pearn 1985, Garber et al. 1985) or the Wall
Street Journal (Otten 1985). However, care is taken to
inform the students, not persuade them, and to introduce
ethical questions only when they are relevant to a particu-
lar concept or lecture. It is useful to give the students, as
part of the day's handout, the complete text of the articles
both for and against an issue. The main points are then
mentioned only during the lecture, letting the students
read the complete articles at their leisure. Because much
of this information is subject to debate, we stress that this
information will not be part of the final examinations.
In the second and third semesters of biochemistry, a
limited number of lectures are given in more specialized
areas. Several lectures are presented on protein and pep-
tide hormones. These cover the cloning of insulin and
growth hormone, and analyses of the growth hormone,
pro-opiomelanocortin, and enkephalin gene families. Ex-
amples of restriction enzyme and southern blotting anal-
ysis of DNA isolated from families with growth hormone
gene deletions are also presented. At this stage two points
are made to the students. First, that some patients (i.e.,
those homozygous for the growth hormone gene deletion)
do not respond to growth hormone treatment because
they recognize growth hormone as a foreign protein and
raise antibodies to it. Second, the ethical problem of
growth hormone use and abuse (Milner 1986, Taylor
1986), which is: should growth hormone be a controlled
substance?
Two lectures are also given on the analysis of diseases
of unknown origin. These focus on the current knowl-
edge regarding the diagnosis of diseases such as Duch-
enne muscular dystrophy, Huntington's disease, and so
on, using restriction fragment length polymorphism
(RFLP) analysis of human DNA samples (Monaco et al.
1985, Folstein et al. 1985). These lectures present what
are probably two of the most difficult concepts in gene
analysis: the relationship of RFLPs to gene inheritance,
and the usefulness of localizing a defective gene to a
region covering some 1-5 X 10' nucleotide pairs on a
particular chromosome. Selected material from the liter-
ature can illustrate the difficult concepts to students. For
instance, the excellent example of RFLPs around a nor-
mal insulin gene (White 1985), or the use of chromo-
somal karyotyping of Wolf-Hirschorn patients, with
subsequent DNA analysis, to localize the Huntington's
disease gene to the tip of the short arm of chromo-
some 4 (Gusella et al. 1985), are helpful. Neither of these
examples are in textbooks; they were obtained from
diligent reading of the scientific literature, then melded
into the lectures. This constant updating of lecture mate-
rial helps to hold the interest of the students.
Overall, the students get a comprehensive exposure to
the role that biotechnology will play in their careers. The
biochemistry department is currently discussing an in-
crease in the time allotted for topics related to bio-
technology. It seems that every week another new and/or
important protein is cloned. Recent examples are the
estrogen and glucocorticoid receptors (Green et al. 1986,
Govindan et al. 1985). It is questionable how much of
this new material the medical student should know. If
necessary, some part of the traditional biochemistry
course must be replaced, because the biochemistry course
has only a finite number of allotted teaching hours.
At the moment, the biochemistry faculty at NEO-
UCOM feel that a reasonable balance has been achieved
between covering the traditional topics of biochemistry
and presenting the latest advances in the understanding
of the molecular basis of diseases. However, this requires




There are distinct advantages to providing either a
separate biotechnology-oriented course to under-
graduates or to ensuring that the topic is covered in
existing biology or biochemistry courses. As bio-
technology is now part of the real world, a suitable back-
ground would enable students to be more appreciative of
the important health, social, and environmental issues
relating to biotechnology. They would also be better
prepared to make career decisions regarding graduate
school programs. It is projected that there will be a
shortage of trained biotechnologists in the near future
(Rigl 1986). In response to this, at least one college (State
University of New York at Fredonia), has instituted a
special biotechnology degree program. The development
of new courses, programs, or the inclusion of bio-
technology into existing programs or courses, is not
without cost. New faculty may have to be hired, or
present faculty members convinced that they should be
teaching something about which they have no knowledge
or even interest.
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Irrespective of the mechanism chosen for increasing
the time given to the teaching of biotechnology, there are
at least two major decisions to be considered. One is
departmental support for this teaching; the other is a
commitment by the lecturer to constantly update the
information that is presented. The tendency is to use one
textbook, that is often out of date even when first pub-
lished, until a newer edition is published or a slightly
more up-to-date alternative is available. Biotechnology is
changing too fast and is too important to be treated so
lightly. However, it must be recognized that a de-
partment's resources are limited and not always available
for new and innovative approaches to teaching.
With some planning it should be possible to introduce
some aspects of biotechnology into many undergraduate
courses. Interesting data are now available regarding the
origin of the serine proteases (Rogers 1985) which would
fit nicely into a biochemistry course. The data on DNA
fingerprinting could be included in a genetics course
(Newmark 1986); the Food and Drug Administration's
approval of a genetically engineered vaccine for hepatitis
B could be discussed in an immunology course (Castro
1986). Whatever data are used, a conscious effort has to
be made by someone to seek out the information and to
work it into the lecture material, since every month there
are more examples of new uses for products derived from
biotechnology.
CHALLENGE OF TEACHING
BIOTECHNOLOGY TO HIGH SCHOOL
SENIORS
If certain aspects of biotechnology are going to be
taught to high school students, then they have to be
taught in a simple, clear, interesting, and understandable
manner. Most of the students will not have the back-
ground for detailed explanations of cloning or bacterial
genetics, nor is it necessary that they should. It should be
possible to explain much of the "recombinant DNA as-
pects of biotechnology" through an understanding of
only a few basic concepts such as the hydrogen bonding
of nucleic acids, or specificity of restriction enzymes. The
use of simple analogies are invaluable. For instance,
the action of a zipper can be used to explain two
complementary strands of nucleic acids. A system using
different colored velcro strips could also be devised to
represent double-stranded DNA and single-stranded
RNA, to explain complementarity, or to show the prin-
ciples of hybridization. Similarly, strips of different
lengths could be used to demonstrate the stability of
hydrogen bonding (i.e., the more hydrogen bonds or
nucleotides, the more stable the double-stranded mole-
cules).
If one wanted to explain the possible deleterious results
of genetic mutations to seniors, one could go into a
detailed explanation of the changes occurring in going
from one nucleotide to another, alterations in hydrogen
binding, amino acids, and so on. The result of this ap-
proach is a bored student. An alternative is to simplify
the system by imagining that the information contained
in a DNA sequence is given by the sentence: THE CAT
SAT ON A MAT. The 3-letter groups are nucleotides; the
word is an amino acid; the sentence represents useful
information. Now it is easy to comprehend the results of
a frameshift or deletion mutation. A possibly harmless
mutation, where one amino acid is substituted for a
similar amino acid, would be explained as THE rAT SAT
ONA MAT. Clearly, the information from the "sentence"
is essentially the same. Even or uneven crossovers
are easily explained using this simple sentence system.
This method is used to teach genetic mutations to
medical students. Once the basics are understood, then
specific examples are given with the clinical results. First,
however, the students must learn a simple, basic set
of examples.
It is also important that the science teachers re-
sponsible for disseminating this or other information be
educated in the basics of biotechnology. This represents
a distinct problem. Many science teachers will have had,
at best, a limited exposure to the subject matter in col-
lege, with probably no further education in this area. It
would be difficult for them to teach something that they
do not really understand. Conceivably, summer work-
shops could be used to train selected high school science
teachers. Care should be taken, however, in choosing the
visiting lecturers. The fact that a lecturer has an extensive
knowledge of biotechnology does not necessarily mean
that that individual has the ability to express it in a clear,
simple manner.
CONCLUSION
At NEOUCOM, the constant updating of the bio-
chemistry lectures, coupled with the presentation of new
material on prenatal diagnosis, gene organization, or
some other aspect relating to human disease has helped
keep Biochemistry-Molecular Pathology a popular and
successful course. The extra time spent by the faculty in
doing this is rewarded by very high attendance at both
lectures and laboratories.
Most student evaluations also support our view that
the course is successful. When asked "what did you find
most valuable about this course", the latest (fall, 1986)
comments included: "going to lectures"; "lectures con-
cerning southern blot techniques and prenatal diagno-
sis"; "genetic section of course made sense for the first
time"; and "I felt I learned a great deal of material that
I can take with me and apply in a medical practice espe-
cially concerning hemolytic anemia and genetics (re-
combined DNA, and so on)". However, not all students
are convinced. Under least valuable, there were: "the last
couple of sessions in cloning. Just a little above my
head"; and "the stress on the genetic basis of disease was
inappropriate. Why do we need to know all the tech-
niques of cloning DNA and genes just because one of the
faculty does research in that area? A majority of the class
was devoted just to gene technology. I think that this is
far too much."
The experience at NEOUCOM also indicates that ma-
terial related to biotechnology could be introduced into
undergraduate and high school curricula. How feasible
this would be is hard to tell. University and high school
instructors have a greater teaching load than medical
school faculty, and may not have the time or the oppor-
tunity to screen the literature for the latest relevant infor-
mation. This is unfortunate because new information
helps attract the students' interest, and biotechnology is
here as part of our daily life, whether we like it or not.
Publications such as Science or Scientific American do pro-
vide current information, but there is nothing like, for
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example, seeing an article on Bloom's syndrome (Willis
and Lindahl 1987) just before updating the next semes-
ter's lectures.
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